Company: BIVIW
Filing Date: 2025-08-04
Form Type: S-1/A
Source: 0001520138-25-000235
Chunk: 117

Company: BIOVIE INC.
Filing Date: 2025-08-04
Form: S-1/A
Chunk 117
---

and presentations, and remains a Fellow of the American Academy of Neurology.

Dr. Chappell’s
qualifications to serve on our Board of Directors are primarily based on her decades of experience in clinical neuroscience and drug
development.

Mr. Kameel D. Farag has served as a director of the Company since 2025. Most recently, he was Chief Financial Officer, Treasurer and head of
business operations at Aspen Neuroscience from 2021 to 2025, where he oversaw tripling the company’s headcount, secured over $150
million in financing, built manufacturing infrastructure and prepared the company for clinical data and a potential future public offering.
Prior to that, he served as Senior Vice President, Finance at Ionis Pharmaceuticals from 2018 to 2021. In addition, Mr. Farag spent over
16 years at Amgen Inc. in a variety of finance and operational roles including Chief Financial Officer of Amgen's Intercontinental Region
from 2013 to 2018 and as its Head of International FP&A and Interim International Chief Financial Officer from 2009 to 2013. Mr.
Farag holds a BA from the University of California, Santa Barbara.

Mr. Farag’s
qualifications to serve on our Board of Directors are primarily based on his experience as a biotech and global finance executive with
a track record of scaling companies through transformational growth.

Mr. Sigmund Rogich has served as a director of the Company since 2020. He
is the CEO and President of The Rogich Communications Group and serves on the Board of Keep Memory Alive, a philanthropic organization
which raises awareness about brain disorders and Alzheimer’s disease. Keep Memory Alive funds clinical trials to advance new treatments
for patients with Alzheimer’s, Huntington’s and Parkinson’s disease, as well as multiple sclerosis. Mr. Rogich was
formerly the U.S. Ambassador to Iceland. He has served as a senior consultant to Presidents Ronald Reagan and George H.W. Bush. Mr. Rogich
serves on multiple boards of directors for charitable causes.

Mr. Rogich’s qualifications to serve on
our Board of Directors are based on his experience in the Communications sector and philanthropic organization raising awareness about
brain disorders. His experience in service as a senior consultant to candidates of the highest office.

Mr. Michael Sherman
has served as a director of the Company since 2017. He retired from his position as a Managing
Director at Barclays Plc in 2018,